Free Trial

DIAGNOS (ADK) Stock Forecast & Price Target

0.00 (0.00%)
(As of 07/24/2024 05:27 PM ET)

DIAGNOS - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 2 Wall Street analysts who have issued ratings for DIAGNOS in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 1 has given a buy rating, and 1 has given a strong buy rating for ADK.

Consensus Price Target

368.75% Upside
High ForecastC$1.50
Average ForecastC$1.50
Low ForecastC$1.50

According to the 2 analysts' twelve-month price targets for DIAGNOS, the average price target is C$1.50. The highest price target for ADK is C$1.50, while the lowest price target for ADK is C$1.50. The average price target represents a forecasted upside of 368.75% from the current price of C$0.32.

TypeCurrent Forecast
7/26/23 to 7/25/24
1 Month Ago
6/26/23 to 6/25/24
3 Months Ago
4/27/23 to 4/26/24
1 Year Ago
7/26/22 to 7/26/23
Consensus Rating
Strong Buy
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$1.50C$1.50C$1.50N/A
Forecasted Upside368.75% Upside237.08% Upside237.08% UpsideN/A
Get DIAGNOS Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ADK and its competitors with MarketBeat's FREE daily newsletter.

ADK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ADK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

DIAGNOS Stock vs. The Competition

TypeDIAGNOSMedical Companies
Consensus Rating Score
Consensus RatingStrong BuyModerate Buy
News Sentiment RatingPositive News
Neutral News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/17/2024Ventum Cap Mkts
0 of 5 stars
S. Quenneville
Subscribe to MarketBeat All Access for the recommendation accuracy rating
12/12/2023Echelon Wealth Partners
1 of 5 stars
 Boost TargetSpeculative BuyC$1.00 ➝ C$1.50+237.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:22 AM ET.

ADK Forecast - Frequently Asked Questions

What is DIAGNOS's forecast for 2024?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for DIAGNOS is C$1.50, with a high forecast of C$1.50 and a low forecast of C$1.50.

Should I buy or sell DIAGNOS stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DIAGNOS in the last year. There is currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" ADK shares.

Does DIAGNOS's stock price have much upside?

According to analysts, DIAGNOS's stock has a predicted upside of 237.08% based on their 12-month stock forecasts.

Has DIAGNOS been upgraded by Wall Street analysts recently?

Over the previous 90 days, DIAGNOS's stock had 1 upgrade by analysts.

What analysts cover DIAGNOS?

DIAGNOS has been rated by research analysts at Ventum Cap Mkts in the past 90 days.

Do Wall Street analysts like DIAGNOS more than its competitors?

Analysts like DIAGNOS more than other "medical" companies. The consensus rating for DIAGNOS is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ADK compares to other companies.

This page (CVE:ADK) was last updated on 7/25/2024 by Staff

From Our Partners